VV116 noninferior to nirmatrelvir-ritonavir for sustained recovery in COVID-19 patients
1. VV116 is noninferior compared to nirmatrelvir-ritonavir for achieving sustained recovery in mild-to-moderate coronavirus disease 2019 (COVID-19) cases. 2. Participants ...